Sarah Lane, PA
Physician Assistant · Maple Grove, MNNPI 1336334192
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,504 of the $4,252 with a category attached, or 82.4%. 26 manufacturers reported payments, led by Medtronic at 28.9% of the total. Among physician assistant clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novo Nordisk$500
- Corcept Therapeutics$344
- Abbott$274
- Esperion Therapeutics, Inc.$258
- Lilly USA, LLC$246
- plus $1K from 20 others
What the payments were for
- Travel & lodging$66316%
- Food & beverage$3,50482%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $1,230 |
| Novo Nordisk | 49 | $500 |
| Corcept Therapeutics | 13 | $344 |
| Abbott | 7 | $274 |
| Esperion Therapeutics, Inc. | 15 | $258 |
| Lilly USA, LLC | 21 | $246 |
| Sanofi-aventis U.S. LLC | 8 | $234 |
| Amgen(2 entities) | 8 | $184 |
| Bayer | 8 | $179 |
| AstraZeneca | 5 | $165 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Mannkind Corporation | 2 | $85 |
| Antares Pharma, Inc. | 5 | $84 |
| Novartis | 4 | $62 |
| Nestle Healthcare Nutrition Inc. | 4 | $55 |
| Tandem Diabetes Care, Inc. | 1 | $45 |
| IBSA Pharma Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $32 |
| Merck | 2 | $30 |
| Amryt Pharma Holdings Ltd | 1 | $26 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$951
- Korlym$129
- FreeStyle Libre 2$120
- NEXLIZET$113
- NEXLETOL$113
- FARXIGA$110
- Saxenda$102
How this compares
$4,252 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 123 | $161,921 |
| TrulicityDulaglutide | 98 | $119,919 |
| JardianceEmpagliflozin | 87 | $110,737 |
| MounjaroTirzepatide | 100 | $110,327 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 48 | $61,375 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 25 | $54,231 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $52,417 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $42,192 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 27 | $31,314 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $27,427 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 172 | $20,320 |
| Novolog FlexpenInsulin Aspart | 81 | $20,115 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $12,285 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $11,953 |
| Humalog Kwikpen U-100Insulin Lispro | 37 | $11,878 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $246 | $241,519240 claims |
| Novo NordiskOzempic | $500 | $161,921123 claims |
| Boehringer IngelheimJardiance | $32 | $110,73787 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $234 | $31,31427 claims |
| AbbVieSynthroid | $14 | $2,08227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Maple Grove
- John IsenbergMaple Grove$92K
- Valerie LessardMaple Grove$9K
- Elliott WiseMaple Grove$6K
- Alexis BolickMaple Grove$5K
- Alexandra AndersonMaple Grove$5K
- Alexandra KoesMaple Grove$4K
- Frederick DemeuseMaple Grove$4K
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.